HDFC Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1896 Cr | ₹1296 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.14 | 2.14 |
| Manager | Dhruv Muchhal | Meeta Shetty |
| ISIN Code | INF179KC1HL7 | INF277K016A9 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | 3.81% | 3.21% |
| 6 Month | 9.86% | 6.57% |
| 1 Year | 7.81% | 1.37% |
| 3 Year | - | 21.38% |
| 5 Year | - | 18.33% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | 3.69% | 2.97% |
| 1 Year | 13.9% | 9.24% |
| 3 Year | - | 20.62% |
| 5 Year | - | 18.28% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 27.59% | 9.76% |
| 3 Year | - | 18.6% |
| 5 Year | - | 15.32% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | - | 16.04% |
| Sharp | - | 0.90% |
| Beta | - | 0.97% |
| Alpha | - | -0.83% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Dhruv Muchhal | Meeta Shetty |
| Total AUM | ₹520687 Cr | ₹17847 Cr |
| Funds Managed | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 7.7 | 4.14 |
| Mid Cap | 30.89 | 37.44 |
| Small Cap | 35.06 | 33.28 |
| Large Cap | 26.35 | 25.14 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.03 | 1.72 |
| Basic Materials | 2.31 | 2.64 |
| Healthcare | 96.66 | 94.07 |
| Financial Services | - | 1.58 |
Top Comparisons
Kotak Nifty Next 50 Index Fund - Regular Plan - Growth Option
3Y Returns17.73%
Motilal Oswal Nifty 500 Index Fund - Regular Plan
3Y Returns15.33%
PGIM India Midcap Fund - Regular Plan - Growth Option
3Y Returns13.2%
Quant Mid Cap Fund-Growth
3Y Returns16.92%
DSP Nifty 50 Equal Weight Index Fund - Regular Plan - Growth
3Y Returns16.9%
LIC MF Nifty 50 Index Fund-Growth
3Y Returns12.58%
Mahindra Manulife Large Cap Fund - Regular Plan - Growth
3Y Returns13.64%
BANDHAN Large Cap Fund - Regular Plan - Growth
3Y Returns16.69%